Masteron 200 mg Prime

How to use Masteron 200 mg Prime

Drostanolone is an anabolic steroid. It is unique in its moderate anabolic action and resistance to aromatisation. It comes in two forms: propionate and enanthate. Masteron 200 mg Prime – is special because it has a longer half-life. This means that injections of the drug will not have to be made as frequently as when using propionate.

Indications for Masteron 200 mg Prime

The steroid is suitable for such groups of athletes:

• bodybuilders;
• dynamophiles;
• weight lifters;
• runners.

The drug has the ability to maintain muscle mass and not lose strength during drying cycles. It does not participate in the recruitment of muscle mass, but only makes existing muscles harder and denser. It improves relief and is able to burn fat. Therefore, it goes well with a slimming diet.

Main indication for Masteron 200 mg Prime: drying cycle.

Side effects

The remedy has a small list of side effects. This is due to the inability to flavour and is a great advantage. However, androgenic side effects can still occur at high doses:

• acne;
• aggressiveness;
• baldness;
• prostate enlargement;
• hirsutism;
• virilisation (in women).

The drug is not recommended for women, although it has already been actively used to treat breast cancer. The steroid is capable of developing male sexual characteristics in women.

Single and combined course

The drug works very well on its own. Enanthate is a longer form, so it can be administered once a week. As a rule of thumb, experienced athletes use about 400 mg of the substance. The dosage can be increased if necessary to achieve a more pronounced effect. However, this increases the risk of side effects. Before taking it, you should consult a doctor.

In combined courses Masteron 200 mg Prime is used together with Winstrol, testosterone, trenbolone. In this case, a synergistic effect is observed.

After the course, it is necessary to undergo special therapy. This helps to restore the hormonal system to its usual mode.

List of references

1. Farooqi V, van den Berg J, Sparreboom A, et al. Comparative analysis of testosterone and dihydrotestosterone uptake by prostate cancer cells and the expression of some steroidogenic enzymes. J Steroid Biochem Mol Biol. 2011;125(3-5):176-184. doi:10.1016/j.jsbmb.2011.04.010
2. Köhn FM, Schöber C, Trefz FK, et al. Androgen metabolism of human benign prostatic tissue in vitro: a comparative study of two different 5 alpha-reductase inhibitors and cyproterone acetate. Prostate. 1993;22(1):59-70. doi:10.1002/pros.2990220108
3. Meikle AW, Mazer NA, Moellmer JF, Stringham JD. Enhanced 5 alpha-reductase activity in patients with the nephrotic syndrome. J Clin Endocrinol Metab. 1992;74(6):1156-1161. doi:10.1210/jcem.74.6.1373221
4. Schröder FH, Roobol MJ. Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer. Curr Opin Urol. 2009;19(3):227-231. doi:10.1097/MOU.0b013e32832d3c07
5. Singh AB, Hsia S, Alaupovic P, et al. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab. 2002;87(1):136-143. doi:10.1210/jcem.87.1.8141